The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
The female side of pharmacotherapy for ADHD—A systematic literature review
Open accessAbstract
OBJECTIVE: This comprehensive review examined sex differences in prescription rates and efficacy or effectiveness of pharmacotherapy treatment in girls and women with attention deficit hyperactivity disorder (ADHD), while identifying gaps in the scientific knowledge on this topic. METHOD: A rigorous electronic database search was carried out in order to identify all published studies on female-specific effects of stimulants and non-stimulants in the treatment of ADHD. In total, 2672 studies were screened of which 21 studies (seven on prescription rates, 14 on effects of pharmacotherapy) met the inclusion criteria and were included for analysis. RESULTS: In all seven studies on ADHD prescription rates, girls received significantly less prescriptions than boys, a difference however no longer seen in adults with the exception of one study. Each of the 14 studies on effectiveness / efficacy found at least one sex-difference in the effects of ADHD pharmacotherapy. CONCLUSION: Several sex-differences are demonstrated in the prescription, usage and efficacy /effectiveness of both stimulant and non-stimulant ADHD pharmacotherapy. A single daily use of MPH may possibly not be optimal for girls with ADHD and ATX may be a promising medication for girls and women with ADHD. The robustness of this result requires further investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additionally, during periods of low oestrogen, increased ADHD symptoms [30,41,91,92] and decreased response to psychostimulant medication [25,42,93,94,95] have been described.”
From A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences (2024) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We developed this female-specific treatment option in response to the dire need expressed by many [1,17,19,23,24,25,26,28,41,55,85], including patients.”
From A Female-Specific Treatment Group for ADHD—Description of the Programme and Qualitative Analysis of First Experiences (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
The Prevalence of DSM-IV Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review
Willcutt, E. G. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0135-8 · Cited by 2,160
Attention Deficit Hyperactivity Disorder. A Handbook for Diagnosis and Treatment
Silver, L. B. (1991) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199107000-00040 · Cited by 1,395
Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1417860 · Cited by 1,181
Greenhill, L. L., Pliszka, S., & Dulcan, M. K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200202001-00003 · Cited by 927
A Meta-Analytic Review of Gender Differences in ADHD
Gershon, J., & Gershon, J. (2002) · Journal of Attention Disorders · doi:10.1177/108705470200500302 · Cited by 875
Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatmen, 3rd ed.
Lyon, G. J., & Coffey, B. J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0621a · Cited by 757
Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, 3rd ed
Lyon, G. J., & Coffey, B. J. (2008) · The Journal of Clinical Psychiatry · Cited by 755
Effect sizes for research: A broad practical approach.
Grissom, R. J., & Kim, J. J. (2005) · Cited by 732
Gender Differences in Attention-Deficit/Hyperactivity Disorder
Rucklidge, J. J. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.01.006 · Cited by 571
Reporting Sex, Gender, or Both in Clinical Research?
Clayton, J. A., & Tannenbaum, C. (2016) · JAMA · doi:10.1001/jama.2016.16405 · Cited by 540
Gender differences in drug responses
Franconi, F., Brunelleschi, S., Steardo, L., & Cuomo, V. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.001 · Cited by 475
Do Women Have More Adverse Drug Reactions?
Rademaker, M. (2001) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200102060-00001 · Cited by 433
Sex differences in predicting ADHD clinical diagnosis and pharmacological treatment
Mowlem, F. D., Rosenqvist, M. A., Martin, J., Lichtenstein, P., Asherson, P. J., & Larsson, H. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1211-3 · Cited by 432
Gender effects on Attention-Deficit/Hyperactivity disorder in adults, revisited
Biederman, J., Faraone, S. V., Monuteaux, M. C., Bober, M., & Cadogen, E. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.003 · Cited by 385
European guidelines on managing adverse effects of medication for ADHD
(for the European Guidelines Group), Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Döpfner, M., Hamilton, R., Hollis, C., et al. (2011) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-010-0140-6 · Cited by 374
Sex differences in ADHD: Conference summary
Arnold, L. E. (1996) · Journal of Abnormal Child Psychology · doi:10.1007/bf01670100 · Cited by 340
Sex differences in ADHD symptom severity
Arnett, A. B., Pennington, B. F., Willcutt, E. G., DeFries, J. C., & Olson, R. K. (2015) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12337 · Cited by 333
ADHD in girls and boys – gender differences in co-existing symptoms and executive function measures
Skogli, E. W., Teicher, M. H., Andersen, P. N., Hovik, K. T., & Øie, M. G. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-298 · Cited by 304
KRATOCHVIL, C. J., HEILIGENSTEIN, J. H., DITTMANN, R., SPENCER, T. J., BIEDERMAN, J., WERNICKE, J., NEWCORN, J. H., CASAT, C., MILTON, D., & MICHELSON, D. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200207000-00008 · Cited by 292
Quinn, P. O., & Madhoo, M. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01596 · Cited by 264
Santema, B. T., Ouwerkerk, W., Tromp, J., Sama, I. E., Ravera, A., Regitz‐Zagrosek, V., Hillege, H. L., Samani, N. J., Zannad, F. M., Dickstein, K., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31792-1 · Cited by 259
ADHD and Female Specific Concerns: A Review of the Literature and Clinical Implications
Nussbaum, N. L. (2012) · Journal of Attention Disorders · doi:10.1177/1087054711416909 · Cited by 241
Adult Attention Deficit–Hyperactivity Disorder
Volkow, N. D., & Swanson, J. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmcp1212625 · Cited by 227
Dittmann, R., Fouche, D. S., Kratochvil, C. J., Heiligenstein, J. H., Spencer, T. J., & Biederman, J. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)80448-x · Cited by 223
Menstrual cycle phase and responses to drugs of abuse in humans
Terner, J. M., & de Wit, H. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.12.007 · Cited by 190
Recent Trends in Childhood Attention-Deficit/Hyperactivity Disorder
Getahun, D., Jacobsen, S. J., Fassett, M. J., Chen, W., Demissie, K., & Rhoads, G. G. (2013) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/2013.jamapediatrics.401 · Cited by 188
ADHD Medication and Substance-Related Problems
Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16060686 · Cited by 187
Barbaresi, W., Katusic, S., Colligan, R., Weaver, A., Leibson, C., & Jacobsen, S. (2006) · Journal of Developmental and Behavioral Pediatrics · doi:10.1097/dbp.0000000000000099 · Cited by 166
Berridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.023 · Cited by 160
Chang, Z., D’Onofrio, B. M., Quinn, P. D., Lichtenstein, P., & Larsson, H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.018 · Cited by 154
Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-012-0286-5 · Cited by 147
Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade
Davidovitch, M., Koren, G., Fund, N., Shrem, M., & Porath, A. (2017) · BMC Pediatrics · doi:10.1186/s12887-017-0971-0 · Cited by 144
Dafny, N., & Yang, P. B. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.10.005 · Cited by 139
Sex and gender influences on pharmacological response: an overview
Franconi, F., & Campesi, I. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.922866 · Cited by 139
Influence of Ethanol and Gender on Methylphenidate Pharmacokinetics and Pharmacodynamics
Patrick, K. S., Straughn, A. B., Minhinnett, R., Yeatts, S. D., Herrin, A. E., DeVane, C. L., Malcolm, R. J., Janis, G. C., & Markowitz, J. S. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100082 · Cited by 137
Hanwella, R., Senanayake, M., & de Silva, V. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-176 · Cited by 137
Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Weaver, A. L., Leibson, C. L., & Jacobsen, S. J. (2006) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200602000-00001 · Cited by 130
Brault, M., & Lacourse, É. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700206 · Cited by 125
Problematic Peer Functioning in Girls with ADHD: A Systematic Literature Review
Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165119 · Cited by 118
Self-citationReed, V. A., Buitelaar, J. K., Anand, E., Day, K. A., Treuer, T., Upadhyaya, H. P., Coghill, D. R., Kryzhanovskaya, L. A., & Savill, N. C. (2016) · CNS Drugs · doi:10.1007/s40263-016-0349-0 · Cited by 113
Rhodes, S. M., Coghill, D. R., & Matthews, K. (2006) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2006.01633.x · Cited by 112
Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study
Piñeiro-Dieguez, B., Balanzá-Martínez, V., García-García, P., Soler-López, B., & the CAT Study Group (2016) · Journal of Attention Disorders · doi:10.1177/1087054713518240 · Cited by 111
Use of ADHD drugs in the Nordic countries: a population-based comparison study
Zoëga, H., Furu, K., Halldórsson, M., Thomsen, P. H., Sourander, A., & Martikainen, J. E. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01607.x · Cited by 107
Robison, R. J., Reimherr, F. W., Marchant, B. K., Faraone, S. V., Adler, L. A., & West, S. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0207 · Cited by 101
Lack of gender effects on subtype outcomes in adults with attention–deficit/hyperactivity disorder
Grevet, E., Bau, C. H. D., Salgado, C. A., Fischer, A. G., Kalil, K., Victor, M., Garcia, C. R., Sousa, N., Rohde, L., & Belmonte-de-Abreu, P. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0639-5 · Cited by 99
Does methylphenidate improve academic performance? A systematic review and meta-analysis
Kortekaas-Rijlaarsdam, A. F., Luman, M., Sonuga-Barke, E., & Oosterlaan, J. (2019) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1106-3 · Cited by 99
Cortese, S., Faraone, S. V., Bernardi, S., Wang, S., & Blanco, C. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09630 · Cited by 97
Comparative Effects of Methylphenidate on ADD Girls and ADD Boys
Pelham, W. E., Walker, J. L., Sturges, J. W., & Hoza, J. (1989) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198909000-00021 · Cited by 94
Biederman, J., Heiligenstein, J. H., Faries, D. E., Galil, N., Dittmann, R., Emslie, G. J., Kratochvil, C. J., Laws, H. F., Schuh, K. J., & Atomoxetine ADHD Study Group (2002) · PEDIATRICS · doi:10.1542/peds.110.6.e75 · Cited by 87
Tucha, O. M., Mecklinger, L., Laufkötter, R., Klein, H. E., Walitza, S., & Lange, K. W. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0437-7 · Cited by 85
Self-citationMcCabe, S. E., Dickinson, K., West, B. T., & Wilens, T. E. (2016) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2016.03.011 · Cited by 82
Executive Impairment Determines ADHD Medication Response: Implications for Academic Achievement
Hale, J. B., Reddy, L. A., Semrud‐Clikeman, M., Hain, L. A., Whitaker, J., Morley, J., Lawrence, K., Smith, A. C. W., & Jones, N. (2011) · Journal of Learning Disabilities · doi:10.1177/0022219410391191 · Cited by 73
Sex Differences in the Response of Children With ADHD to Once-Daily Formulations of Methylphenidate
Sonuga-Barke, E. J. S., Coghill, D., Markowitz, J. S., Swanson, J. M., Vandenberghe, M., & HATCH, S. J. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31804659f1 · Cited by 66
Thorell, L. B., & Rydell, A. (2008) · Child Care Health and Development · doi:10.1111/j.1365-2214.2008.00869.x · Cited by 66
Karlstad, Ø., Zoëga, H., Furu, K., Bahmanyar, S., Martikainen, J. E., Kieler, H., & Pottegård, A. (2016) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-016-2125-y · Cited by 65
Semrud‐Clikeman, M., Pliszka, S. R., & Mario Liotti, A. (2008) · Neuropsychology · doi:10.1037/0894-4105.22.3.329 · Cited by 64
Monuteaux, M. C., Mick, E. O., Faraone, S. V., & Biederman, J. (2009) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02152.x · Cited by 63
Santosh, P. J., Sattar, S., & Canagaratnam, M. (2011) · CNS Drugs · doi:10.2165/11593070-000000000-00000 · Cited by 62 · cited 3×
“With regard to ADHD pharmacotherapy, two classes of medication exist; stimulants and non-stimulants [35].”
BackgroundInfluentialSavill, N. C., Buitelaar, J. K., Anand, E., Day, K. A., Treuer, T., Upadhyaya, H. P., & Coghill, D. (2015) · CNS Drugs · doi:10.1007/s40263-014-0224-9 · Cited by 59
Gender Differences in Cardiovascular Drugs
Stolarz, A. J., & Rusch, N. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6611-8 · Cited by 55
WILSON, H., Cox, D. J., Merkel, R. L., Moore, M. E., & Coghill, D. (2006) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2006.06.016 · Cited by 55
Anderson, K. N., Ailes, E. C., Danielson, M. L., Lind, J. N., Farr, S. L., Broussard, C. S., & Tinker, S. C. (2018) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6702a3 · Cited by 54
Marchant, B. K., Reimherr, F. W., Halls, C., Williams, E. D., Strong, R. E., Kondo, D. G., Soni, P., & Robison, R. J. (2011) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0054-2 · Cited by 49
Effects of methylphenidate on memory functions of adults with ADHD
Fuermaier, A. B. M., Tucha, L., Koerts, J., Weisbrod, M., Lange, K. W., Aschenbrenner, S., & Tucha, O. M. (2016) · Applied Neuropsychology Adult · doi:10.1080/23279095.2015.1124108 · Cited by 48
Self-citationde Zeeuw, E. L., van Beijsterveldt, C. E. M., Ehli, E. A., de Geus, E. J. C., & Boomsma, D. I. (2017) · Behavior Genetics · doi:10.1007/s10519-017-9836-4 · Cited by 46
Pharmacological Treatment of ADHD and the Short and Long Term Effects on Sleep
Huang, Y.-S., Tsai, M.-H., & Guilleminault, C. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796197179 · Cited by 44
Differential Effects of Methylphenidate on Problem Solving in Adults With ADHD
Tucha, L., Tucha, O. M., Sontag, T. A., Stasik, D., Laufkötter, R., & Lange, K. W. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709356391 · Cited by 42
Self-citationHaimov-Kochman, R., & Berger, I. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00191 · Cited by 40
Human sex differences in d‐amphetamine self‐administration
Vansickel, A. R., Stoops, W. W., & Rush, C. R. (2010) · Addiction · doi:10.1111/j.1360-0443.2009.02858.x · Cited by 36
Pottegård, A., Bjerregaard, B. K., Kortegaard, L. S., & Zoëga, H. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12325 · Cited by 34
Stimulant Medication and Prefrontal Functional Connectivity During Working Memory in ADHD
Sheridan, M. A., Hinshaw, S. P., & D’Esposito, M. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709347444 · Cited by 34
Ernst, E., & Pittler, M. H. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01707.x · Cited by 33
Prevalence of ADHD in Qatari School-Age Children
Bradshaw, L., & Kamal, M. (2014) · Journal of Attention Disorders · doi:10.1177/1087054713517545 · Cited by 32
Fredriksen, M., & Peleikis, D. E. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12477 · Cited by 31
Biederman, J., Wigal, S. B., Spencer, T. J., McGough, J. J., & Mays, D. A. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.02.008 · Cited by 30
Faraone, S. V., & Glatt, S. J. (2010) · Journal of Attention Disorders · doi:10.1177/1087054709332472 · Cited by 30
Günther, T., Herpertz‐Dahlmann, B., & Konrad, K. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0060 · Cited by 29
DSM-IV ADHD: Prevalence based on parent and teacher ratings of Malaysian primary school children
Gomez, R., & Hafetz, N. (2011) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2010.12.003 · Cited by 24
Guanfacine ER for the treatment of adolescent attention-deficit/hyperactivity disorder
Bukstein, O. G., & Head, J. C. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.721778 · Cited by 21
Song, I., & Shin, J. (2016) · Epidemiology and Health · doi:10.4178/epih.e2016045 · Cited by 20
Awadalla, N. J., Ali, O., Elshaer, S., & Eissa, M. O. (2016) · Eastern Mediterranean Health Journal · doi:10.26719/2016.22.8.586 · Cited by 19
Wehmeier, P. M., Schacht, A., Escobar, R., Amaia Hervas, G., & Dickson, R. A. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-011-0070-2 · Cited by 16
Afeti, K., & Nyarko, S. (2017) · Annals of General Psychiatry · doi:10.1186/s12991-017-0135-5 · Cited by 16
Wang, L., Chen, C., & Huang, Y. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0175 · Cited by 15
Kortekaas-Rijlaarsdam, A. F., Luman, M., Sonuga-Barke, E. J. S., Bet, P. M., & Oosterlaan, J. (2017) · Journal of Attention Disorders · doi:10.1177/1087054717713640 · Cited by 14
Klein, T., Panther, S. G., Woo, T. M., Odom‐Maryon, T., & Daratha, K. B. (2016) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0255 · Cited by 13
Kortekaas-Rijlaarsdam, A. F., Luman, M., Sonuga-Barke, E. J. S., Bet, P. M., & Oosterlaan, J. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000671 · Cited by 11
Münir, K. (2015) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn20152801001 · Cited by 8
eHaimov-Kochman, R., & eBerger, I. (2014) · Frontiers in Human Neuroscience · Cited by 8
Effects of methylphenidate treatment on quality of life in adolescents
Karcı, C. K., Toros, F., Tahiroğlu, A. Y., & Metin, Ö. (2018) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2018310101 · Cited by 7
Input From the Deep South Compartment
Holford, N. H. G. (1995) · Clinical Pharmacokinetics · doi:10.2165/00003088-199529030-00001 · Cited by 4
Mowlem, F. D. (2019) · Research Portal (King's College London) · Cited by 1
Research works printed but not linked: 2
- P. Hodgkins, 2012, Amfetamine and methylphenidate pharmacotherapys for attention-deficit/hyperactivity disorder: Complementary treatment options. European Child &, Adolescent Psychiatry, 21, 477, 10.1007/s00787-012-0286-5 · DOI · Paper page
- J. M. Swanson, 1992, School-based assessments and interventions for ADD students
Cited by
Sorted by citations
Hinshaw, S. P., Nguyen, P. T., O’Grady, S. M., & Rosenthal, E. A. (2022) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13480 · Cited by 424
Sex and gender in neurodevelopmental conditions
Bölte, S., Neufeld, J., Marschik, P. B., Williams, Z. J., Gallagher, L., & Lai, M.-C. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00774-6 · Cited by 249
Why are females less likely to be diagnosed with ADHD in childhood than males?
Martin, J. (2024) · The Lancet Psychiatry · doi:10.1016/s2215-0366(24)00010-5 · Cited by 200
Brikell, I., Yao, H., Li, L., Astrup, A., Gao, L., Gillies, M. B., Xie, T., Zhang‐James, Y., Dalsgaard, S., Engeland, A., et al. (2023) · The Lancet Psychiatry · doi:10.1016/s2215-0366(23)00332-2 · Cited by 96
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
Jaeschke, R. R., Sujkowska, E., & Sowa-Kućma, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05946-0 · Cited by 105
Metadata
- Authors
- Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O.
- Affiliations
- University of Groningen (NL)
- Corresponding author
- Kok, Francien M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-09-18
- Volume
- 15
- Issue
- 9
- Pages
- e0239257
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7500607
- OpenAlex
- W3087626112
- Cited by
- 86
- References
- 95
- Citations by year
- 2026: 12 · 2025: 26 · 2024: 14 · 2023: 13 · 2022: 15 · 2021: 6
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Social Sciences › Arts and Humanities › Philosophy › Neuroethics, Human Enhancement, Biomedical Innovations
- Keywords
- attention deficit hyperactivity disorder, ADHD medication, sex differences, girls, women, stimulant medication, non-stimulant medication, methylphenidate, atomoxetine, prescription rates, treatment efficacy
- MeSH terms
- Atomoxetine Hydrochloride, Adolescent, Adult, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Female, Humans, Male, Men, Methylphenidate, Drug Prescriptions, Sex Characteristics, Databases, Factual, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
